DE60329627D1 - Hydrolysestabile maleimidendgruppen-enthaltende polymere - Google Patents
Hydrolysestabile maleimidendgruppen-enthaltende polymereInfo
- Publication number
- DE60329627D1 DE60329627D1 DE60329627T DE60329627T DE60329627D1 DE 60329627 D1 DE60329627 D1 DE 60329627D1 DE 60329627 T DE60329627 T DE 60329627T DE 60329627 T DE60329627 T DE 60329627T DE 60329627 D1 DE60329627 D1 DE 60329627D1
- Authority
- DE
- Germany
- Prior art keywords
- maleidend
- stabile
- hydrolysis
- polymers containing
- group polymers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229920000642 polymer Polymers 0.000 title abstract 2
- 230000007062 hydrolysis Effects 0.000 title 1
- 238000006460 hydrolysis reaction Methods 0.000 title 1
- 239000002243 precursor Substances 0.000 abstract 1
- 229920003169 water-soluble polymer Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/30—Post-polymerisation treatment, e.g. recovery, purification, drying
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/333—Polymers modified by chemical after-treatment with organic compounds containing nitrogen
- C08G65/33331—Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing imide group
- C08G65/33337—Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing imide group cyclic
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/333—Polymers modified by chemical after-treatment with organic compounds containing nitrogen
- C08G65/33396—Polymers modified by chemical after-treatment with organic compounds containing nitrogen having oxygen in addition to nitrogen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2203/00—Applications
- C08L2203/02—Applications for biomedical use
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
- Polyethers (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43721102P | 2002-12-31 | 2002-12-31 | |
| PCT/US2003/041699 WO2004060965A2 (en) | 2002-12-31 | 2003-12-31 | Hydrolytically stable maleimide-terminated polymers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60329627D1 true DE60329627D1 (de) | 2009-11-19 |
Family
ID=32713147
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60329627T Expired - Lifetime DE60329627D1 (de) | 2002-12-31 | 2003-12-31 | Hydrolysestabile maleimidendgruppen-enthaltende polymere |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7432330B2 (de) |
| EP (1) | EP1578842B1 (de) |
| JP (1) | JP4490290B2 (de) |
| KR (1) | KR101025143B1 (de) |
| CN (1) | CN100343304C (de) |
| AT (1) | ATE444984T1 (de) |
| AU (1) | AU2003300133B2 (de) |
| CA (1) | CA2509153C (de) |
| DE (1) | DE60329627D1 (de) |
| MX (1) | MXPA05007151A (de) |
| WO (1) | WO2004060965A2 (de) |
Families Citing this family (103)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7432331B2 (en) | 2002-12-31 | 2008-10-07 | Nektar Therapeutics Al, Corporation | Hydrolytically stable maleimide-terminated polymers |
| JP4490413B2 (ja) | 2003-01-06 | 2010-06-23 | ネクター セラピューティクス アラバマ，コーポレイション | チオール選択的水溶性ポリマー誘導体 |
| KR101131411B1 (ko) * | 2003-07-22 | 2012-07-05 | 넥타르 테라퓨틱스 | 중합체 알코올로부터 관능화된 중합체의 제조 방법 |
| US7790835B2 (en) | 2003-12-03 | 2010-09-07 | Nektar Therapeutics | Method of preparing maleimide functionalized polymers |
| GB0329825D0 (en) * | 2003-12-23 | 2004-01-28 | Celltech R&D Ltd | Biological products |
| US6887952B1 (en) * | 2004-02-12 | 2005-05-03 | Biosite, Inc. | N-aryl-carbamic acid ester-derived and valeric acid ester-derived cross-linkers and conjugates, and methods for their synthesis and use |
| MXPA06010764A (es) * | 2004-03-23 | 2006-12-15 | Amgen Inc | Metodos y composiciones de proteinas quimicamente modificadas. |
| HUE033776T2 (en) | 2004-11-12 | 2018-01-29 | Bayer Healthcare Llc | FVIII site-specific modification |
| EP1827501B2 (de) * | 2004-12-21 | 2013-11-20 | Nektar Therapeutics | Stabilisierte polymer-thiol-reagenzien |
| US8012488B2 (en) * | 2005-02-18 | 2011-09-06 | Nof Corporation | Polyoxyalkylene derivative |
| US20060233740A1 (en) * | 2005-03-23 | 2006-10-19 | Bossard Mary J | Conjugates of an hGH moiety and a polymer |
| WO2006110776A2 (en) | 2005-04-12 | 2006-10-19 | Nektar Therapeutics Al, Corporation | Polyethylene glycol cojugates of antimicrobial agents |
| SI1888641T1 (sl) | 2005-05-18 | 2012-05-31 | Ablynx Nv | Proteini ki vežejo serum albumin |
| ATE524509T1 (de) | 2005-07-18 | 2011-09-15 | Nektar Therapeutics | Verzweigte funktionalisierte polymere unter verwendung von verzweigten polyolen als kernen |
| JP5600240B2 (ja) * | 2005-07-19 | 2014-10-01 | ウェルズ ファーゴ バンク ナショナル アソシエイション | 重合体マレイミド類を調製する方法 |
| ES2390286T3 (es) | 2005-12-16 | 2012-11-08 | Nektar Therapeutics | Conjugados poliméricos de GLP-1 |
| US7743730B2 (en) * | 2005-12-21 | 2010-06-29 | Lam Research Corporation | Apparatus for an optimized plasma chamber grounded electrode assembly |
| AU2007216998B8 (en) | 2006-02-21 | 2013-12-19 | Nektar Therapeutics | Segmented degradable polymers and conjugates made therefrom |
| US20070238163A1 (en) * | 2006-04-05 | 2007-10-11 | Golova Julia B | Covalent attachment of biomolecules to solid supports by a polymerization method |
| DK2084183T3 (da) | 2006-10-13 | 2010-08-16 | Lilly Co Eli | Pegyleret PTH som PTH-receptormodulatorer og anvendelser deraf |
| PT2101821E (pt) | 2006-12-15 | 2014-10-03 | Baxter Int | Fator conjugado viia-ácido (poli)siálico com prolongamento do tempo de meia vida in vivo |
| US9156914B2 (en) | 2006-12-19 | 2015-10-13 | Ablynx N.V. | Amino acid sequences directed against a metalloproteinase from the ADAM family and polypeptides comprising the same for the treatment of ADAM-related diseases and disorders |
| EP2115004A2 (de) | 2006-12-19 | 2009-11-11 | Ablynx N.V. | Gegen gpcrs gerichtete aminosäuresequenzen und diese enthaltende polypeptide zur behandlung von mit gpcr in zusammenhang tehenden krankheiten und erkrankungen |
| US8066999B2 (en) * | 2007-01-18 | 2011-11-29 | Eli Lilly And Company | PEGylated Aβ fab |
| WO2009012162A2 (en) | 2007-07-16 | 2009-01-22 | Allvivo Vascular, Inc. | Antimicrobial constructs |
| JP2011504740A (ja) | 2007-11-27 | 2011-02-17 | アブリンクス エン．ヴェー． | ヘテロ二量体サイトカイン及び／又はこれらの受容体に指向性を有するアミノ酸配列、並びにこれを含むポリペプチド |
| AU2009235467A1 (en) | 2008-04-07 | 2009-10-15 | Ablynx Nv | Single variable domains against the Notch pathways |
| AU2009239641B2 (en) * | 2008-04-24 | 2013-11-07 | Cantab Biopharmaceuticals Patents Limited | Factor IX conjugates with extended half-lives |
| EP2326349B1 (de) | 2008-07-21 | 2015-02-25 | Polytherics Limited | Neue reagenzien und verfahren zur konjugation von biologischen molekülen |
| BRPI0919979A2 (pt) | 2008-10-29 | 2015-12-15 | Wyeth Llc | formulações de moléculas de ligação de antígeno de domínio único |
| US10118962B2 (en) | 2008-10-29 | 2018-11-06 | Ablynx N.V. | Methods for purification of single domain antigen binding molecules |
| US9260508B2 (en) | 2008-12-19 | 2016-02-16 | Ablynx N.V. | Method for generation of immunoglobulin sequences |
| CN105399828B (zh) | 2009-04-10 | 2021-01-15 | 埃博灵克斯股份有限公司 | 用于治疗il-6r相关疾病和病症的改进的针对il-6r的氨基酸序列和包含其的多肽 |
| NZ597314A (en) | 2009-06-05 | 2013-07-26 | Ablynx Nv | Monovalent, bivalent and trivalent anti human respiratory syncytial virus (hrsv) nanobody constructs for the prevention and/or treatment of respiratory tract infections |
| DK2451839T3 (da) | 2009-07-10 | 2020-07-13 | Ablynx Nv | Fremgangsmåde til produktion af variable domæner |
| US8642737B2 (en) | 2010-07-26 | 2014-02-04 | Baxter International Inc. | Nucleophilic catalysts for oxime linkage |
| TWI537006B (zh) | 2009-07-27 | 2016-06-11 | 巴克斯歐塔公司 | 凝血蛋白接合物 |
| US8809501B2 (en) | 2009-07-27 | 2014-08-19 | Baxter International Inc. | Nucleophilic catalysts for oxime linkage |
| RU2744370C2 (ru) | 2009-07-27 | 2021-03-05 | Баксалта Инкорпорейтед | Конъюгаты белков свертывания крови |
| AU2010277438B2 (en) | 2009-07-27 | 2015-08-20 | Baxalta GmbH | Glycopolysialylation of non-blood coagulation proteins |
| US20110195494A1 (en) | 2009-10-02 | 2011-08-11 | Boehringer Ingelheim International Gmbh | Dll4-binging molecules |
| UY32920A (es) | 2009-10-02 | 2011-04-29 | Boehringer Ingelheim Int | Moleculas de unión biespecíficas para la terapia anti-angiogénesis |
| WO2011056799A1 (en) * | 2009-11-05 | 2011-05-12 | Sangart, Inc. | Methods for preparing polyethylene glycol maleimide using n-(2-hydroxyethyl) maleimide as a starting material |
| WO2011064382A1 (en) | 2009-11-30 | 2011-06-03 | Ablynx N.V. | Improved amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections |
| US8962807B2 (en) | 2009-12-14 | 2015-02-24 | Ablynx N.V. | Single variable domain antibodies against OX40L, constructs and therapeutic use |
| WO2011083140A1 (en) | 2010-01-08 | 2011-07-14 | Ablynx Nv | Immunoglobulin single variable domain directed against human cxcr4 |
| US9120855B2 (en) | 2010-02-10 | 2015-09-01 | Novartis Ag | Biologic compounds directed against death receptor 5 |
| EA201201227A1 (ru) | 2010-03-03 | 2013-04-30 | Бёрингер Ингельхайм Интернациональ Гмбх | Бипаратопные а-бета-связывающие полипептиды |
| EP2552962B1 (de) | 2010-03-26 | 2016-03-23 | Ablynx N.V. | Einzelne, gegen cxcr7 gerichtete variable immunoglobulindomänen |
| US9101674B2 (en) | 2010-03-29 | 2015-08-11 | Vib Vzw | Targeting and in vivo imaging of tumor-associated macrophages |
| US9556273B2 (en) | 2010-03-29 | 2017-01-31 | Vib Vzw | Anti-macrophage mannose receptor single variable domains for targeting and in vivo imaging of tumor-associated macrophages |
| GB201007356D0 (en) | 2010-04-30 | 2010-06-16 | Leverton Licence Holdings Ltd | Conjugated factor VIIa |
| WO2011146518A2 (en) | 2010-05-17 | 2011-11-24 | Cebix Inc. | Pegylated c-peptide |
| EP3546483A1 (de) | 2010-05-20 | 2019-10-02 | Ablynx N.V. | Biologische stoffe im zusammenhang mit her3 |
| EP2593476A2 (de) | 2010-07-16 | 2013-05-22 | Ablynx N.V. | Modifizierte einzeldomänen-antigen-bindungsmoleküle und ihre verwendung |
| GB201014715D0 (en) | 2010-09-06 | 2010-10-20 | Vib Vzw | Nanobodies stabilizing functional conformational states of GPCRS |
| US20120225081A1 (en) | 2010-09-03 | 2012-09-06 | Boehringer Ingelheim International Gmbh | Vegf-binding molecules |
| MX343085B (es) | 2010-11-08 | 2016-10-24 | Novartis Ag | Polipeptidos que se enlazan a cxcr2. |
| EA032056B1 (ru) | 2010-12-22 | 2019-04-30 | Баксалта Инкорпорейтид | Конъюгат терапевтического белка и производного жирной кислоты, способы получения конъюгата терапевтического белка и производного жирной кислоты (варианты) |
| US8440309B2 (en) | 2011-01-31 | 2013-05-14 | Confluent Surgical, Inc. | Crosslinked polymers with the crosslinker as therapeutic for sustained release |
| CN103533952B (zh) | 2011-03-15 | 2017-02-15 | 诺沃—诺迪斯克有限公司 | 包含半胱氨酸置换的人胰岛素类似物和衍生物 |
| US20150158948A9 (en) | 2011-03-28 | 2015-06-11 | Francis Descamps | Bispecific anti-cxcr7 immunoglobulin single variable domains |
| MX361242B (es) | 2011-03-30 | 2018-11-30 | Ablynx Nv | Anticuerpos de dominio sencillo contra tnf-alfa y usos de los mismos. |
| US9527925B2 (en) | 2011-04-01 | 2016-12-27 | Boehringer Ingelheim International Gmbh | Bispecific binding molecules binding to VEGF and ANG2 |
| US20130078247A1 (en) | 2011-04-01 | 2013-03-28 | Boehringer Ingelheim International Gmbh | Bispecific binding molecules binding to dii4 and ang2 |
| UA117218C2 (uk) | 2011-05-05 | 2018-07-10 | Мерк Патент Гмбх | Поліпептид, спрямований проти il-17a, il-17f та/або il17-a/f |
| CA2837840C (en) | 2011-06-10 | 2020-08-04 | Mersana Therapeutics, Inc. | Protein-polymer-drug conjugates |
| US8815226B2 (en) | 2011-06-10 | 2014-08-26 | Mersana Therapeutics, Inc. | Protein-polymer-drug conjugates |
| EP3345919A1 (de) | 2011-06-21 | 2018-07-11 | VIB vzw | Bindungsdomänen gegen gpcr: g-proteinkomplexe und daraus abgeleitete verwendungen |
| EA028183B1 (ru) | 2012-02-27 | 2017-10-31 | Бёрингер Ингельхайм Интернациональ Гмбх | Cx3cr1-связывающие полипептиды |
| US9328174B2 (en) | 2012-05-09 | 2016-05-03 | Novartis Ag | Chemokine receptor binding polypeptides |
| EP2855526B1 (de) | 2012-05-24 | 2018-11-07 | VIB vzw | Einzelne immunoglobulin d'immunoglobulin variable antimakrophagen-mannose-rezeptordomänen zur anzielung und in-vivo-bildgebung von tumorassoziierten makrophagen |
| DK2953973T3 (da) | 2013-02-05 | 2019-08-12 | Vib Vzw | Muskarine acetylcholinreceptor-bindemidler og anvendelser deraf |
| JP6499090B2 (ja) | 2013-03-15 | 2019-04-10 | ブイアイビー ブイゼットダブリュＶｉｂ Ｖｚｗ | 心血管疾患において使用するための抗マクロファージマンノース受容体単一可変ドメイン |
| AU2014331714B2 (en) | 2013-10-11 | 2019-05-02 | Mersana Therapeutics, Inc. | Protein-polymer-drug conjugates |
| ES2754397T3 (es) | 2013-10-11 | 2020-04-17 | Asana Biosciences Llc | Conjugados de proteína-polímero-fármaco |
| CN103965357B (zh) | 2013-12-31 | 2016-08-17 | 嘉和生物药业有限公司 | 一种抗人rankl抗体 |
| EP3099707B1 (de) | 2014-01-30 | 2021-12-29 | Vib Vzw | Opioidrezeptorbinder und verwendungen davon |
| MA39711A (fr) * | 2014-04-03 | 2015-10-08 | Nektar Therapeutics | Conjugués d'une fraction d'il-15 et d'un polymère |
| NL2013661B1 (en) | 2014-10-21 | 2016-10-05 | Ablynx Nv | KV1.3 Binding immunoglobulins. |
| CN106794259B (zh) | 2014-10-14 | 2021-07-16 | 宝力泰锐克斯有限公司 | 采用包含含有peg部分的离去基团的试剂缀合肽或蛋白质的方法 |
| EP3085709B1 (de) | 2014-12-28 | 2019-08-21 | Genor Biopharma Co., Ltd | Humanisierte antikörper gegen menschliches rankl, pharmazeutische zusammensetzung und verwendung davon |
| CN109071627B (zh) | 2016-02-05 | 2023-04-04 | 奥里尼斯生物科学私人有限公司 | Cd8结合剂 |
| WO2017153402A1 (en) | 2016-03-07 | 2017-09-14 | Vib Vzw | Cd20 binding single domain antibodies |
| US11186641B2 (en) | 2016-03-17 | 2021-11-30 | Oslo Universitetssykehus Hf | Fusion proteins targeting tumour associated macrophages for treating cancer |
| JP7394526B2 (ja) | 2016-03-30 | 2023-12-08 | コンバテック・テクノロジーズ・インコーポレイテッド | 変性された創傷包帯 |
| US11273224B2 (en) | 2016-04-14 | 2022-03-15 | Polytherics Limited | Conjugates and conjugating reagents comprising a linker that includes at least two (-CH2—CH2—O-) units in a ring |
| CA3023881A1 (en) | 2016-05-13 | 2017-11-16 | Orionis Biosciences Nv | Therapeutic targeting of non-cellular structures |
| GB201608936D0 (en) | 2016-05-20 | 2016-07-06 | Polytherics Ltd | Novel conjugates and novel conjugating reagents |
| GB201615725D0 (en) | 2016-09-15 | 2016-11-02 | Polytherics Ltd | Novel cytotoxic agents and conjugates thereof |
| JP7222888B2 (ja) | 2016-11-16 | 2023-02-15 | アブリンクス エン．ヴェー． | Ｃｄ１２３及びｔｃｒアルファ／ベータに結合することが可能なｔ細胞動員ポリペプチド |
| CN110573172A (zh) | 2017-02-06 | 2019-12-13 | 奥里尼斯生物科学有限公司 | 靶向的工程化干扰素及其用途 |
| IL268346B2 (en) | 2017-02-06 | 2024-08-01 | Orionis Biosciences BV | Targeted chimeric proteins and their uses |
| CA3060410A1 (en) | 2017-05-15 | 2018-11-22 | Nektar Therapeutics | Long-acting interleukin-15 receptor agonists and related immunotherapeutic compositions and methods |
| MX2019014448A (es) | 2017-06-02 | 2020-02-10 | Merck Patent Gmbh | Inmunoglobulinas de enlace a mmp13. |
| BR112019024333A2 (pt) | 2017-06-02 | 2020-07-28 | Merck Patent Gmbh | imunoglobulinas de ligação adamts |
| TW202413408A (zh) | 2017-06-02 | 2024-04-01 | 比利時商艾伯林克斯公司 | 結合聚集蛋白聚糖之免疫球蛋白 |
| WO2018220236A1 (en) | 2017-06-02 | 2018-12-06 | Merck Patent Gmbh | Polypeptides binding adamts5, mmp13 and aggrecan |
| EP3704160A1 (de) | 2017-10-31 | 2020-09-09 | VIB vzw | Neuartige antigenbindende chimäre proteine und verfahren und verwendungen davon |
| US11896643B2 (en) | 2018-02-05 | 2024-02-13 | Orionis Biosciences, Inc. | Fibroblast binding agents and use thereof |
| CN117321076A (zh) | 2021-02-19 | 2023-12-29 | 美国卫生及公众服务部代表 | 中和SARS-CoV-2的单结构域抗体 |
| WO2024083843A1 (en) | 2022-10-18 | 2024-04-25 | Confo Therapeutics N.V. | Amino acid sequences directed against the melanocortin 4 receptor and polypeptides comprising the same for the treatment of mc4r-related diseases and disorders |
| WO2024133935A1 (en) | 2022-12-23 | 2024-06-27 | Ablynx Nv | Protein-based conjugation carriers |
Family Cites Families (98)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2206317A1 (en) | 1972-11-16 | 1974-06-07 | Inst Francais Du Petrole | Coating compsn prepd. from a polyhydroxy cpd. - by (trans)esterification with a maleimido-benzoic acid deriv |
| US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| JPS5821649B2 (ja) | 1974-02-13 | 1983-05-02 | 古河電気工業株式会社 | フホウワポリエステルケイジユシノ セイゾウホウホウ |
| US4288612A (en) * | 1976-06-21 | 1981-09-08 | Chevron Research Company | Deposit control additives |
| US4179551A (en) | 1977-10-25 | 1979-12-18 | Trw, Inc. | Low temperature curable compliant bismaleimide compositions |
| US4229550A (en) | 1978-12-11 | 1980-10-21 | Trw Inc. | Flexibilized vinyl polybutadiene maleimide resins |
| GB2047418B (en) | 1979-01-25 | 1983-02-23 | Fuji Photo Film Co Ltd | Silver halide photographic materials |
| JPS57192418A (en) | 1981-05-21 | 1982-11-26 | Mitsui Toatsu Chem Inc | Curable resin composition |
| JPS57205413A (en) | 1981-06-11 | 1982-12-16 | Mitsui Toatsu Chem Inc | Curable resin composition |
| JPS5815515A (ja) | 1981-07-21 | 1983-01-28 | Mitsui Toatsu Chem Inc | 熱硬化性樹脂組成物 |
| JPS5840374A (ja) | 1981-09-04 | 1983-03-09 | Mitsui Toatsu Chem Inc | 防汚塗料 |
| JPS60156395A (ja) | 1984-01-17 | 1985-08-16 | Mihama Hisaharu | 修飾リパーゼ |
| US4675414A (en) | 1985-03-08 | 1987-06-23 | The United States Of America As Represented By The Secretary Of The Navy | Maleimidomethyl-carbonate polyethers |
| US4839345A (en) | 1985-03-09 | 1989-06-13 | Nippon Oil And Fats Co., Ltd. | Hydrated adhesive gel and method for preparing the same |
| JPS6328645A (ja) | 1986-07-23 | 1988-02-06 | 東レ株式会社 | 積層フイルム |
| JPS63277619A (ja) | 1987-05-11 | 1988-11-15 | Nippon Oil & Fats Co Ltd | シ−ト状貼着剤の製造方法 |
| JPS6462338A (en) | 1987-09-02 | 1989-03-08 | Bridgestone Corp | Rubber composition |
| JPS6488129A (en) | 1987-09-29 | 1989-04-03 | Nippon Oils & Fats Co Ltd | Sheet-like detecting material for inspecting leakage |
| EP0318162A3 (de) * | 1987-11-25 | 1990-11-07 | Texaco Development Corporation | Bismaleinimid-Derivate |
| EP0357110A1 (de) | 1988-08-05 | 1990-03-07 | Akzo N.V. | Zwei-Komponenten-Anstrichmasse, härtbar bei Zimmertemperatur durch eine Diels-Alder-Reaktion |
| JPH02149335A (ja) | 1988-11-30 | 1990-06-07 | Nippon Oil & Fats Co Ltd | キトサン・ゼラチン架橋ゲル |
| US5166322A (en) | 1989-04-21 | 1992-11-24 | Genetics Institute | Cysteine added variants of interleukin-3 and chemical modifications thereof |
| US5620689A (en) | 1989-10-20 | 1997-04-15 | Sequus Pharmaceuuticals, Inc. | Liposomes for treatment of B-cell and T-cell disorders |
| US5527528A (en) | 1989-10-20 | 1996-06-18 | Sequus Pharmaceuticals, Inc. | Solid-tumor treatment method |
| US6552170B1 (en) | 1990-04-06 | 2003-04-22 | Amgen Inc. | PEGylation reagents and compounds formed therewith |
| US5766897A (en) | 1990-06-21 | 1998-06-16 | Incyte Pharmaceuticals, Inc. | Cysteine-pegylated proteins |
| SG47099A1 (en) | 1991-03-15 | 1998-03-20 | Amgen Boulder Inc | Pegylation of polypeptides |
| AU6368394A (en) | 1993-03-23 | 1994-10-11 | Liposome Technology, Inc. | Polymer-polypeptide composition and method |
| US6326353B1 (en) | 1993-03-23 | 2001-12-04 | Sequus Pharmaceuticals, Inc. | Enhanced circulation effector composition and method |
| US6180134B1 (en) | 1993-03-23 | 2001-01-30 | Sequus Pharmaceuticals, Inc. | Enhanced ciruclation effector composition and method |
| FR2706900B1 (de) | 1993-06-25 | 1995-09-08 | Flamel Tech Sa | |
| GB9317618D0 (en) | 1993-08-24 | 1993-10-06 | Royal Free Hosp School Med | Polymer modifications |
| AU685187B2 (en) | 1993-10-29 | 1998-01-15 | Incyte Pharmaceuticals, Inc. | Chimeric proteins including protease nexin-1 variants |
| JPH07132685A (ja) | 1993-11-11 | 1995-05-23 | Fuji Photo Film Co Ltd | 熱転写材料 |
| CN1110681A (zh) | 1994-04-20 | 1995-10-25 | 中国科学院上海生物化学研究所 | 一种新型的蛋白质及多肽巯基聚乙二醇(peg)化试剂 |
| US5583114A (en) | 1994-07-27 | 1996-12-10 | Minnesota Mining And Manufacturing Company | Adhesive sealant composition |
| JP3399100B2 (ja) | 1994-07-27 | 2003-04-21 | 日本油脂株式会社 | オキシアルキレン誘導体 |
| JP3525516B2 (ja) | 1994-10-27 | 2004-05-10 | 日本油脂株式会社 | 反応性小胞体、小胞体修飾剤および製造方法 |
| US5997861A (en) | 1994-10-31 | 1999-12-07 | Burstein Laboratories, Inc. | Antiviral supramolecules containing target-binding molecules and therapeutic molecules bound to spectrin |
| MY114204A (en) | 1994-11-15 | 2002-08-30 | Shell Int Research | A cross-linked resin |
| US5932462A (en) | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
| US5585484A (en) | 1995-04-19 | 1996-12-17 | Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University | Hemoglobin crosslinkers |
| WO1996040285A1 (en) | 1995-06-07 | 1996-12-19 | Imarx Pharmaceutical Corp. | Novel targeted compositions for diagnostic and therapeutic use |
| US6521211B1 (en) | 1995-06-07 | 2003-02-18 | Bristol-Myers Squibb Medical Imaging, Inc. | Methods of imaging and treatment with targeted compositions |
| US6139819A (en) | 1995-06-07 | 2000-10-31 | Imarx Pharmaceutical Corp. | Targeted contrast agents for diagnostic and therapeutic use |
| WO1998002743A1 (en) | 1996-07-15 | 1998-01-22 | Sensors Technology Company B.V. | Sensors |
| US6306923B1 (en) | 1996-09-12 | 2001-10-23 | Sartomer Company, Inc. | Ultraviolet or visible light polymerizable and/or crosslinkable maleimide-functional coating compositions |
| US6271339B1 (en) | 1996-09-12 | 2001-08-07 | Sartomer Company, Inc. | Prepolymers having maleimide functions the process for preparing them and their uses |
| AU4373297A (en) | 1996-09-19 | 1998-04-14 | Diagnocure Inc. | Polyethyleneglycol conjugated nanoerythrosomes, method of making same and use thereof |
| US6261537B1 (en) | 1996-10-28 | 2001-07-17 | Nycomed Imaging As | Diagnostic/therapeutic agents having microbubbles coupled to one or more vectors |
| US6331289B1 (en) | 1996-10-28 | 2001-12-18 | Nycomed Imaging As | Targeted diagnostic/therapeutic agents having more than one different vectors |
| CN1238700A (zh) | 1996-10-28 | 1999-12-15 | 奈科姆成像有限公司 | 诊断和/或治疗剂的改进或与其相关的改进 |
| US6210707B1 (en) | 1996-11-12 | 2001-04-03 | The Regents Of The University Of California | Methods of forming protein-linked lipidic microparticles, and compositions thereof |
| WO1998022092A1 (en) | 1996-11-22 | 1998-05-28 | The Regents Of The University Of California | Transport of liposomes across the blood-brain barrier |
| DE19652544A1 (de) | 1996-12-17 | 1998-06-18 | Wacker Chemie Gmbh | Härtbare Organosiloxanmassen |
| AU747242B2 (en) | 1997-01-08 | 2002-05-09 | Proligo Llc | Bioconjugation of macromolecules |
| ATE342729T1 (de) | 1997-01-15 | 2006-11-15 | Phoenix Pharmacologics Inc | Modifizierter tumor-nekrosefaktor |
| US5844020A (en) | 1997-03-31 | 1998-12-01 | Xerox Corporation | Phase change ink compositions |
| US6183738B1 (en) | 1997-05-12 | 2001-02-06 | Phoenix Pharamacologics, Inc. | Modified arginine deiminase |
| JP3599160B2 (ja) | 1997-05-16 | 2004-12-08 | 大日本インキ化学工業株式会社 | マレイミド誘導体を含有する活性エネルギー線硬化性組成物及び該活性エネルギー線硬化性組成物の硬化方法 |
| EP1012184B1 (de) | 1997-07-14 | 2007-10-10 | Bolder Biotechnology, Inc. | Derivate des wachstumshormons und verwandte proteine |
| US6495136B1 (en) | 1998-03-26 | 2002-12-17 | The Procter & Gamble Company | Proteases having modified amino acid sequences conjugated to addition moieties |
| WO1999048928A1 (en) | 1998-03-26 | 1999-09-30 | Sun Chemical Corporation | Water compatible energy curable compositions containing maleimide derivatives |
| JPH11349877A (ja) | 1998-04-23 | 1999-12-21 | Tektronix Inc | 相変化インク・キャリア組成物 |
| ATE265525T1 (de) | 1998-04-28 | 2004-05-15 | Amersham Health As | Verbesserung von trennungsverfahren |
| GB9812545D0 (en) | 1998-06-10 | 1998-08-05 | Celltech Therapeutics Ltd | Biological products |
| JP2002521666A (ja) | 1998-07-21 | 2002-07-16 | バースタイン テクノロジーズ，インコーポレイティド | 光ディスクをベースとするアッセイ装置および方法 |
| JP4214579B2 (ja) | 1998-11-13 | 2009-01-28 | Ｄｉｃ株式会社 | マレイミド誘導体を含有する活性エネルギー線硬化性インキ及び該硬化性インキの硬化方法 |
| JP2000144041A (ja) | 1998-11-13 | 2000-05-26 | Dainippon Ink & Chem Inc | マレイミド誘導体を含有する木質材表面被覆用活性エネルギー線硬化性組成物及び該組成物の硬化方法 |
| JP4113978B2 (ja) | 1998-11-17 | 2008-07-09 | Ｄｉｃ株式会社 | マレイミド誘導体を含有する活性エネルギー線硬化性樹脂組成物 |
| JP2000191700A (ja) * | 1998-12-28 | 2000-07-11 | Kyowa Hakko Kogyo Co Ltd | 持続型消化管運動ペプチド |
| EP1046394A3 (de) | 1999-04-19 | 2001-10-10 | ImaRx Pharmaceutical Corp. | Neue Zusammensetzungen zur Verwendung bei der Verabreichung von Verbindungen in das Zellinnere |
| JP2000306605A (ja) | 1999-04-22 | 2000-11-02 | Dainippon Ink & Chem Inc | 活性エネルギー線硬化性高分子固体電解質およびその製造方法 |
| JP2000319252A (ja) | 1999-05-10 | 2000-11-21 | Dainippon Ink & Chem Inc | マレイミド誘導体の製造方法 |
| WO2001007484A2 (en) * | 1999-07-22 | 2001-02-01 | The Procter & Gamble Company | Protease conjugates having sterically protected clip sites |
| US6303119B1 (en) | 1999-09-22 | 2001-10-16 | The Procter & Gamble Company | Personal care compositions containing subtilisin enzymes bound to water insoluble substrates |
| US7220401B2 (en) | 1999-09-24 | 2007-05-22 | Barnes-Jewish Hospital | Blood clot-targeted nanoparticles |
| US6180598B1 (en) | 1999-10-07 | 2001-01-30 | Deanna J. Nelson | Covalently modified hemoglobin having low temperature-dependent oxygen-binding function |
| JP2001172554A (ja) | 1999-12-21 | 2001-06-26 | Dainippon Ink & Chem Inc | マレイミド誘導体を含有する活性エネルギー線硬化性金属被覆組成物 |
| CA2395254C (en) * | 1999-12-24 | 2010-05-11 | Kyowa Hakko Kogyo Co., Ltd. | Branched polyalkylene glycols |
| US6602498B2 (en) | 2000-02-22 | 2003-08-05 | Shearwater Corporation | N-maleimidyl polymer derivatives |
| JP4701497B2 (ja) | 2000-03-07 | 2011-06-15 | Ｄｉｃ株式会社 | マレイミド誘導体の製造方法 |
| JP2001294777A (ja) | 2000-04-14 | 2001-10-23 | Dainippon Ink & Chem Inc | グラフト化顔料およびその製造方法 |
| JP2002121221A (ja) | 2000-08-09 | 2002-04-23 | Dainippon Ink & Chem Inc | 光硬化性着色組成物 |
| TW593427B (en) | 2000-12-18 | 2004-06-21 | Nektar Therapeutics Al Corp | Synthesis of high molecular weight non-peptidic polymer derivatives |
| JP4803412B2 (ja) | 2001-03-14 | 2011-10-26 | Ｄｉｃ株式会社 | マレイミド誘導体を含有する光配向材料及び光配向膜の製造方法 |
| JP4756296B2 (ja) | 2001-03-14 | 2011-08-24 | Ｄｉｃ株式会社 | マレイミド誘導体及びそれを用いた光配向膜の製造方法 |
| JP4142569B2 (ja) * | 2001-06-22 | 2008-09-03 | 協和醗酵工業株式会社 | 軟膏剤 |
| JP2003040939A (ja) | 2001-07-26 | 2003-02-13 | Dainippon Ink & Chem Inc | 活性エネルギー線硬化性樹脂組成物 |
| JP4123856B2 (ja) * | 2001-07-31 | 2008-07-23 | 日油株式会社 | 生体関連物質の修飾剤およびポリオキシアルキレン誘導体の製造方法 |
| US20030149307A1 (en) | 2001-10-24 | 2003-08-07 | Baxter International Inc. | Process for the preparation of polyethylene glycol bis amine |
| US20030153491A1 (en) | 2002-01-11 | 2003-08-14 | Winslow Robert M. | Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin |
| JP4587631B2 (ja) | 2002-01-30 | 2010-11-24 | Ｄｉｃ株式会社 | 熱硬化性樹脂組成物 |
| JP2003241337A (ja) | 2002-02-18 | 2003-08-27 | Konica Corp | 光熱写真画像形成材料 |
| US6815078B2 (en) | 2002-03-06 | 2004-11-09 | Eastman Kodak Company | Substrate for protein microarray containing functionalized polymer |
| CA2509260C (en) | 2002-12-31 | 2012-10-02 | Nektar Therapeutics Al, Corporation | Maleamic acid polymer derivatives and their bioconjugates |
| JP4490413B2 (ja) | 2003-01-06 | 2010-06-23 | ネクター セラピューティクス アラバマ，コーポレイション | チオール選択的水溶性ポリマー誘導体 |
| CA2558583C (en) | 2004-03-15 | 2013-07-09 | Nektar Therapeutics Al, Corporation | Polymer-based compositions and conjugates of hiv entry inhibitors |
-
2003
- 2003-12-31 WO PCT/US2003/041699 patent/WO2004060965A2/en active Application Filing
- 2003-12-31 MX MXPA05007151A patent/MXPA05007151A/es active IP Right Grant
- 2003-12-31 AU AU2003300133A patent/AU2003300133B2/en not_active Expired
- 2003-12-31 US US10/751,274 patent/US7432330B2/en active Active
- 2003-12-31 JP JP2004564914A patent/JP4490290B2/ja not_active Expired - Lifetime
- 2003-12-31 AT AT03800391T patent/ATE444984T1/de not_active IP Right Cessation
- 2003-12-31 DE DE60329627T patent/DE60329627D1/de not_active Expired - Lifetime
- 2003-12-31 KR KR1020057012482A patent/KR101025143B1/ko active IP Right Grant
- 2003-12-31 CA CA2509153A patent/CA2509153C/en not_active Expired - Lifetime
- 2003-12-31 CN CNB2003801080107A patent/CN100343304C/zh not_active Expired - Lifetime
- 2003-12-31 EP EP03800391A patent/EP1578842B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004060965A2 (en) | 2004-07-22 |
| KR101025143B1 (ko) | 2011-04-01 |
| MXPA05007151A (es) | 2005-09-21 |
| CN100343304C (zh) | 2007-10-17 |
| KR20050098852A (ko) | 2005-10-12 |
| WO2004060965A3 (en) | 2004-10-07 |
| JP2006512445A (ja) | 2006-04-13 |
| EP1578842B1 (de) | 2009-10-07 |
| ATE444984T1 (de) | 2009-10-15 |
| EP1578842A2 (de) | 2005-09-28 |
| JP4490290B2 (ja) | 2010-06-23 |
| CA2509153A1 (en) | 2004-07-22 |
| US20040204548A1 (en) | 2004-10-14 |
| US7432330B2 (en) | 2008-10-07 |
| AU2003300133B2 (en) | 2008-11-13 |
| CN1732206A (zh) | 2006-02-08 |
| AU2003300133A1 (en) | 2004-07-29 |
| CA2509153C (en) | 2013-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60329627D1 (de) | Hydrolysestabile maleimidendgruppen-enthaltende polymere | |
| ATE310009T1 (de) | Reaktionssysteme zur herstellung von n- (phosphonomethyl)glyzin verbindungen | |
| DE60135029D1 (de) | Verwendung von löslichen ctla4-mutanten zur behandlung von rheumatoider arthritis | |
| DE502006004410D1 (de) | Verfahren zur herstellung von pfropfpolymerisaten | |
| DE19983785T1 (de) | Systeme und Verfahren zur Herstellung medizinisch verwendbarer Radioisotopen | |
| ATE305908T1 (de) | Verfahren und vorrichtung zur herstellung von mineralwolle | |
| NO20025795D0 (no) | Undervanns hydrokarbon-produksjonssystem | |
| PT1303632E (pt) | Oligossacarideos de galactomanano e processo para a sua preparacao bem como sua utilizacao | |
| DE69905722D1 (de) | Verfahren zur Herstellung texturierter Gegenstände | |
| DE69835357D1 (de) | Verfahren zur Herstellung von Synthesegas | |
| DE59901318D1 (de) | Verfahren und anlage zur herstellung von aerogelen | |
| DE50109023D1 (de) | Vorrichtung zur Herstellung von Wellrohren | |
| SE9804003D0 (sv) | A method of producing drug particles | |
| DE60324813D1 (de) | Verfahren zur Herstellung von Wellenleitern | |
| ATE529569T1 (de) | Verfahren zur papierherstellung mit enzymbehandeltem schlamm, und produkte | |
| DE60330099D1 (de) | Verfahren und Anordnungen zur Herstellung, Feststellung und Übertragung von Identifikatoren | |
| NO20035380D0 (no) | Fremgangsmåte for dannelse av m degree nster | |
| AU2003283361A8 (en) | Processes of forming mineral fibres | |
| DE50104778D1 (de) | Verfahren zur herstellung von polyisobutenylphenolen | |
| DE60101848D1 (de) | Hochfunktionalisierte polymere und verfahren zur herstellung davon | |
| MXPA04000446A (es) | 4-aminociclohexanoles sustituidos. | |
| DE69900936D1 (de) | Elektrolysezelle zur Erzeugung von Gas | |
| DE60229654D1 (de) | Verfahren zur herstellung von granuliertem abfallkunststoff und verfahren zur thermischen zersetzung des kunststoffs | |
| DE60320801D1 (de) | Vorrichtung zur harnstoffherstellung | |
| DE59900393D1 (de) | Verfahren zur Herstellung von Organochlorsilanen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |